You can buy or sell SURF and other stocks, options, ETFs, and crypto commission-free!
Surface Oncology, Inc. Common Stock, also called Surface Oncology, is a clinical-stage immuno-oncology company, which focuses on biological pathways critical to the immunosuppressive tumor microenvironment and the development of next-generation cancer therapies. Read More The company was founded by David S. Grayzel in 2014 and is headquartered in Cambridge, MA.
52 Week High
52 Week Low
-$0.61 per share